As of 2026-03-23, the Relative Valuation of Vaxcyte Inc (PCVX) is (115.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 54.72 USD, the upside of Vaxcyte Inc based on Relative Valuation is -310.5%.
The range of the Relative Valuation is (100.57) - (129.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 26.3x | 22.2x |
| Forward P/E multiples | 18.4x - 24.4x | 21.1x |
| Fair Price | (100.57) - (129.76) | (115.19) |
| Upside | -283.8% - -337.1% | -310.5% |
| Date | P/E |
| 2026-03-19 | -10.11 |
| 2026-03-18 | -10.19 |
| 2026-03-17 | -10.42 |
| 2026-03-16 | -10.44 |
| 2026-03-13 | -10.25 |
| 2026-03-12 | -10.55 |
| 2026-03-11 | -10.80 |
| 2026-03-10 | -10.93 |
| 2026-03-09 | -11.14 |
| 2026-03-06 | -11.13 |
| 2026-03-05 | -10.94 |
| 2026-03-04 | -11.29 |
| 2026-03-03 | -11.23 |
| 2026-03-02 | -11.64 |
| 2026-02-27 | -11.59 |
| 2026-02-26 | -11.26 |
| 2026-02-25 | -11.83 |
| 2026-02-24 | -11.52 |
| 2026-02-23 | -11.31 |
| 2026-02-20 | -10.98 |
| 2026-02-19 | -10.76 |
| 2026-02-18 | -10.54 |
| 2026-02-17 | -10.01 |
| 2026-02-13 | -10.16 |
| 2026-02-12 | -10.32 |
| 2026-02-11 | -10.39 |
| 2026-02-10 | -10.32 |
| 2026-02-09 | -10.43 |
| 2026-02-06 | -10.54 |
| 2026-02-05 | -10.12 |
| 2026-02-04 | -10.38 |
| 2026-02-03 | -10.46 |
| 2026-02-02 | -10.78 |
| 2026-01-30 | -10.06 |
| 2026-01-29 | -9.92 |
| 2026-01-28 | -9.64 |
| 2026-01-27 | -10.20 |
| 2026-01-26 | -10.02 |
| 2026-01-23 | -9.90 |
| 2026-01-22 | -10.11 |
| 2026-01-21 | -9.43 |
| 2026-01-20 | -8.92 |
| 2026-01-16 | -8.75 |
| 2026-01-15 | -9.02 |
| 2026-01-14 | -9.11 |
| 2026-01-13 | -8.64 |
| 2026-01-12 | -8.61 |
| 2026-01-09 | -8.65 |
| 2026-01-08 | -8.51 |
| 2026-01-07 | -8.65 |